Related Experiment Video
Updated: Aug 8, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Gene therapy for cardiac arrhythmias
J Kevin Donahue1, Kan Kikuchi, Tetsuo Sasano
1Division of Cardiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. kdonahue@jhmi.edu
Myocardial gene transfer aids cardiac disease research but faces therapeutic translation challenges. Future arrhythmia gene therapy hinges on overcoming current obstacles for human applications.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Genetics
Background:
- Myocardial gene transfer is established for studying cardiac disease pathophysiology.
- Therapeutic translation of gene transfer for cardiac conditions lags behind research applications.
- New therapeutic strategies are urgently needed for cardiac arrhythmias.
Purpose of the Study:
- To review the utility of gene transfer in assessing cardiac cellular electrophysiology.
- To examine the application of in vivo gene transfer for treating cardiac arrhythmias.
- To identify current challenges hindering cardiac gene therapy development.
Main Methods:
- Literature review of gene transfer applications in cardiac electrophysiology.
- Analysis of in vivo gene transfer studies targeting arrhythmias.
- Discussion of existing problems in cardiac gene therapy.
Main Results:
- Gene transfer effectively evaluates cellular electrophysiology in cardiac models.
- In vivo gene transfer shows potential for treating common arrhythmias.
- Significant hurdles remain in the clinical translation of cardiac gene therapy.
Conclusions:
- Cardiac gene therapy is an emerging field with substantial potential.
- Overcoming current technical and safety challenges is crucial for future human applications.
- Further research is required to realize the therapeutic promise of gene transfer for arrhythmias.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias

